The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 18, 2006
Filed:
Feb. 27, 2004
Pier Francesco Cirillo, Woodbury, CT (US);
Donghong Amy Gao, Hopewell Junction, NY (US);
Daniel R. Goldberg, Redding, CT (US);
Abdelhakim Hammach, Danbury, CT (US);
Ming-hong Hao, Ridgefield, CT (US);
Victor Marc Kamhi, Danbury, CT (US);
Neil Moss, Ridgefield, CT (US);
Matthew Russell Netherton, Danbury, CT (US);
Kevin Chungeng Qian, New Milford, CT (US);
Mark Stephen Ralph, Beacon Falls, CT (US);
Lifen Wu, New Milford, CT (US);
Zhaoming Xiong, Danbury, CT (US);
Ronald A. Aungst, Jr., Clifton Park, NY (US);
Pier Francesco Cirillo, Woodbury, CT (US);
Donghong Amy Gao, Hopewell Junction, NY (US);
Daniel R. Goldberg, Redding, CT (US);
Abdelhakim Hammach, Danbury, CT (US);
Ming-Hong Hao, Ridgefield, CT (US);
Victor Marc Kamhi, Danbury, CT (US);
Neil Moss, Ridgefield, CT (US);
Matthew Russell Netherton, Danbury, CT (US);
Kevin Chungeng Qian, New Milford, CT (US);
Mark Stephen Ralph, Beacon Falls, CT (US);
Lifen Wu, New Milford, CT (US);
Zhaoming Xiong, Danbury, CT (US);
Ronald A. Aungst, Jr., Clifton Park, NY (US);
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT (US);
Abstract
Disclosed are compounds of formula (I) Where Ar, X, Y, Q, W, R, R, R, Rand Rare defined herein. The compounds of the invention inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. The compounds are also useful for treating diseases or conditions related to oncology and anticoagulant or fibrinolytic therapy. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.